ExploreOutcomeRepeat Surgery
Outcome

Repeat Surgery

Also known as: Any repeat surgery (recurrent prolapse surgery or mesh complication surgery) REPEAT SURG REVISION SURG Reoperation Reoperation (qualifier value) Repeat Surgery Revision Surgeries Revision Surgery Revision, Surgical SURG REPEAT SURG REVISION Surgery, Repeat +2 more
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (27)

None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46
None
adverse

Vaginal mesh augmentation for anterior prolapse was associated with a significantly higher 5-year risk of any repeat surgery compared with native tissue repair (15.2% vs 9.8%, p<0.0001; adjusted HR 1.

Effect: adverse; HR 1.33; CI: 95%CI 1.20, 1.46

Size: HR 1.33 CI: 95%CI 1.20, 1.46

Papers (1)